The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $6.47

Today's change-0.34 -4.99%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $6.47

Today's change-0.34 -4.99%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.

Spectrum Pharmaceuticals Inc down (U.S.)$0.34

Spectrum Pharmaceuticals Inc closed sharply lower Friday, dropping (U.S.)$0.34 or 4.99% to (U.S.)$6.47. Shares have lost 4.29% over the last five days, but have gained 7.30% over the last year to date. This security has underperformed the S&P 500 by 4.85% during the last year.

Key company metrics

  • Open(U.S.) $6.46
  • Previous close(U.S.) $6.81
  • High(U.S.) $6.61
  • Low(U.S.) $6.40
  • Bid / Ask(U.S.) $6.01 / (U.S.) $7.50
  • YTD % change+7.30%
  • Volume925,807
  • Average volume (10-day)773,464
  • Average volume (1-month)775,738
  • Average volume (3-month)822,978
  • 52-week range(U.S.) $4.14 to (U.S.) $7.74
  • Beta1.42
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.53
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue44502945
Total other revenue--------
Total revenue44502945
Gross profit37442039
Total cost of revenue7686
Total operating expense50534545
Selling / general / administrative22211923
Research & development15151010
Depreciation / amortization61077
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-6-3-160
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-9-4-19-2
Income after tax-9-4-19-2
Income tax, total0000
Net income-9-4-19-2
Total adjustments to net income--------
Net income before extra. items-9-4-19-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-9-4-19-2
Inc. avail. to common incl. extra. items-9-4-19-2
Diluted net income-9-4-19-2
Dilution adjustment--------
Diluted weighted average shares66636665
Diluted EPS excluding extraordinary itemsvalue per share-0.14-0.07-0.28-0.04
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.14-0.07-0.28-0.04